Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic methodologies: serology, endoscopy, and radiology.

T Dassopoulos1

  • 1Department of Medicine, Meyerhoff Inflammatory Bowel Disease Center, Johns Hopkins University, 600 North Wolfe Street/Blalock 463, Baltimore, MD 21287, USA. tdassopo@jhmi.edu

Current Gastroenterology Reports
|November 7, 2001
PubMed
Summary

Diagnosing inflammatory bowel diseases like Crohn's disease and ulcerative colitis now includes serological markers such as perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA), aiding in disease prediction and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Alimentary pharmacology & therapeutics·2013
Same author

Augmenting capsule endoscopy diagnosis: a similarity learning approach.

Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention·2010
Same author

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases.

Genes and immunity·2007
Same author

Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature.

Annals of medicine·2001
Same author

Evolving treatment strategies for inflammatory bowel disease.

Annual review of medicine·2001
Same author

Acute pancreatitis in human immunodeficiency virus-infected patients: a review.

The American journal of medicine·1999

Area of Science:

  • Gastroenterology
  • Immunology
  • Diagnostic Medicine

Background:

  • Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are traditionally diagnosed using clinical, radiologic, endoscopic, and histologic data.
  • Serum biomarkers, such as perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA), have emerged as valuable additions to the diagnostic toolkit for IBD.

Purpose of the Study:

  • To review the evolving role of serological markers and advanced imaging in the diagnosis and management of IBD.
  • To highlight the utility of pANCA and ASCA in differentiating IBD subtypes and predicting disease course.

Main Methods:

  • Review of existing literature on diagnostic modalities for IBD.
  • Analysis of studies investigating the correlation of pANCA and ASCA with specific IBD phenotypes.

Related Experiment Videos

  • Evaluation of the role of Magnetic Resonance Imaging (MRI) and leukocyte scintigraphy in identifying CD.

    • Main Results:

    • UC-associated pANCA primarily targets nuclear antigens, while studies suggest pANCA in CD may react with histone H1 and microbial antigens.
    • ASCA levels correlate with small bowel disease in CD, with higher levels associated with more aggressive disease.
    • MRI enteroclysis demonstrates efficacy in detecting both luminal and extraluminal complications of CD.

    Conclusions:

    • Serological markers like pANCA and ASCA, alongside advanced imaging techniques, enhance the diagnostic accuracy and prognostic capabilities in IBD.
    • These tools may aid in predicting the progression of indeterminate colitis and identifying high-risk patients for dysplasia and cancer in Crohn's colitis.